133 related articles for article (PubMed ID: 33901898)
1. Beyond direct Nrf2 activation; reinvestigating 1,2,4-oxadiazole scaffold as a master key unlocking the antioxidant cellular machinery for cancer therapy.
Ayoup MS; Abu-Serie MM; Abdel-Hamid H; Teleb M
Eur J Med Chem; 2021 Aug; 220():113475. PubMed ID: 33901898
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant and antitumor activities of new synthesized aromatic C-nucleoside derivatives.
El Sadek MM; Abd El-Dayem NS; Hassan SY; Mostafa MA; Yacout GA
Molecules; 2014 Apr; 19(4):5163-90. PubMed ID: 24759075
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential.
Afifi OS; Shaaban OG; Abd El Razik HA; Shams El-Dine SEA; Ashour FA; El-Tombary AA; Abu-Serie MM
Bioorg Chem; 2019 Jun; 87():821-837. PubMed ID: 30999135
[TBL] [Abstract][Full Text] [Related]
4. Molecular Docking, Antioxidant, Anticancer and Antileishmanial Effects of Newly Synthesized Quinoline Derivatives.
Malghani Z; Khan AU; Faheem M; Danish MZ; Nadeem H; Ansari SF; Maqbool M
Anticancer Agents Med Chem; 2020; 20(13):1516-1529. PubMed ID: 32416701
[TBL] [Abstract][Full Text] [Related]
5. Pyrazoline analogs as potential anticancer agents and their apoptosis, molecular docking, MD simulation, DNA binding and antioxidant studies.
Rana M; Arif R; Khan FI; Maurya V; Singh R; Faizan MI; Yasmeen S; Dar SH; Alam R; Sahu A; Ahmad T; Rahisuddin
Bioorg Chem; 2021 Mar; 108():104665. PubMed ID: 33571809
[TBL] [Abstract][Full Text] [Related]
6. In Silico, Cytotoxic and Antioxidant Potential of Novel Ester, 3-hydroxyoctyl -5
Hussain S; Ullah F; Ayaz M; Ali Shah SA; Ali Shah AU; Shah SM; Wadood A; Aman W; Ullah R; Shahat AA; Nasr FA
Drug Des Devel Ther; 2019; 13():4195-4205. PubMed ID: 31849451
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel of 2, 5-disubstituted 1, 3, 4- oxadiazole derivatives and their in vitro anti-inflammatory, anti-oxidant evaluation, and molecular docking study.
Kashid BB; Salunkhe PH; Dongare BB; More KR; Khedkar VM; Ghanwat AA
Bioorg Med Chem Lett; 2020 Jun; 30(12):127136. PubMed ID: 32280025
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Anticancer Activity of New ((Furan-2-yl)-1,3,4-thiadiazolyl)-1,3,4-oxadiazole Acyclic Sugar Derivatives.
Kassem AF; Nassar IF; Abdel-Aal MT; Awad HM; El-Sayed WA
Chem Pharm Bull (Tokyo); 2019; 67(8):888-895. PubMed ID: 31366838
[TBL] [Abstract][Full Text] [Related]
9. Amino Acid Conjugates of Aminothiazole and Aminopyridine as Potential Anticancer Agents: Synthesis, Molecular Docking and in vitro Evaluation.
Naz S; Shah FA; Nadeem H; Sarwar S; Tan Z; Imran M; Ali T; Li JB; Li S
Drug Des Devel Ther; 2021; 15():1459-1476. PubMed ID: 33833504
[TBL] [Abstract][Full Text] [Related]
10. Isothymusin, a Potential Inhibitor of Cancer Cell Proliferation: An In Silico and In Vitro Investigation.
Singh S; Kumari P; Hussain Y; Luqman S; Meena A; Kanaojia D
Curr Top Med Chem; 2020; 20(21):1898-1909. PubMed ID: 32648844
[TBL] [Abstract][Full Text] [Related]
11. Anti-Lung Cancer Activities of 1,2,3-Triazole Curcumin Derivatives via Regulation of the MAPK/NF-κB/STAT3 Signaling Pathways.
Zhi TX; Liu KQ; Cai KY; Zhao YC; Li ZW; Wang X; He XH; Sun XY
ChemMedChem; 2022 Feb; 17(3):e202100676. PubMed ID: 34773680
[TBL] [Abstract][Full Text] [Related]
12. Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.
Ahsan MJ; Choupra A; Sharma RK; Jadav SS; Padmaja P; Hassan MZ; Al-Tamimi ABS; Geesi MH; Bakht MA
Anticancer Agents Med Chem; 2018; 18(1):121-138. PubMed ID: 28425854
[TBL] [Abstract][Full Text] [Related]
13. Facile One-Pot Synthesis of Tellurium Nanorods as Antioxidant and Anticancer Agents.
Huang W; Wu H; Li X; Chen T
Chem Asian J; 2016 Aug; 11(16):2301-11. PubMed ID: 27325381
[TBL] [Abstract][Full Text] [Related]
14. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
El-Sayed NA; Nour MS; Salem MA; Arafa RK
Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole derivatives as potent antiproliferative agents via a hybrid pharmacophore approach.
Kaneko D; Ninomiya M; Yoshikawa R; Ono Y; Sonawane AD; Tanaka K; Nishina A; Koketsu M
Bioorg Chem; 2020 Nov; 104():104293. PubMed ID: 33010622
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy.
Shamsi F; Hasan P; Queen A; Hussain A; Khan P; Zeya B; King HM; Rana S; Garrison J; Alajmi MF; Rizvi MMA; Zahid M; Imtaiyaz Hassan M; Abid M
Bioorg Chem; 2020 May; 98():103754. PubMed ID: 32200329
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, cytotoxicity, and molecular docking of substituted 3-(2-methylbenzofuran-3-yl)-5-(phenoxymethyl)-1,2,4-oxadiazoles.
Mokenapelli S; Thalari G; Vadiyaala N; Yerrabelli JR; Irlapati VK; Gorityala N; Sagurthi SR; Chitneni PR
Arch Pharm (Weinheim); 2020 Jun; 353(6):e2000006. PubMed ID: 32309890
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anti cancer activity.
Pidugu VR; Yarla NS; Pedada SR; Kalle AM; Satya AK
Bioorg Med Chem; 2016 Nov; 24(21):5611-5617. PubMed ID: 27665180
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antioxidant activity of styrylsulfonylmethyl 1,3,4-oxadiazoles, pyrazolyl/isoxazolyl-1,3,4-oxadiazoles.
Mallikarjuna Reddy G; Muralikrishna A; Padmavathi V; Padmaja A; Krishna Tilak T; Appa Rao C
Chem Pharm Bull (Tokyo); 2013; 61(12):1291-7. PubMed ID: 24292790
[TBL] [Abstract][Full Text] [Related]
20. 1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells.
Valente S; Trisciuoglio D; De Luca T; Nebbioso A; Labella D; Lenoci A; Bigogno C; Dondio G; Miceli M; Brosch G; Del Bufalo D; Altucci L; Mai A
J Med Chem; 2014 Jul; 57(14):6259-65. PubMed ID: 24972008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
